Relative efficacy of parenteral haloperidol and thiothixene for the emergency treatment of acutely excited and agitated patients
- PMID: 338270
Relative efficacy of parenteral haloperidol and thiothixene for the emergency treatment of acutely excited and agitated patients
Abstract
In this double-blind study, haloperidol (n = 15) and thiothixene (n = 15), administered parenterally in emergency rooms and outpatient facilities to 30 acutely excited, agitated psychotic patients in hourly doses of 4 mg. or 8 mg., as needed over a four-hour period (total dosage ranging from 4 to 32 mg.), achieved rapid tranquilization in 30 patients. Significant improvement was shown over a six-hour period on BPRS Total Score, the four factors--Thinking Disorder, Anergic state, Excitement and Disorientation, and Depression and also on hourly ratings of 17 symptoms of a Psychiatric Target Symptom Profile. No significant differences were found between the haloperidol-treated and thiothixene-treated groups. Few adverse reactions were noted, all of them mild, the most frequent being drowsiness in six patients.
Similar articles
-
Psychopharmacological correlates of post-psychotic depression: a double-blind investigation of haloperidol vs thiothixene in outpatient schizophrenia.J Clin Psychiatry. 1982 Mar;43(3):105-10. J Clin Psychiatry. 1982. PMID: 7037757 Clinical Trial.
-
A double-blind randomized clinical trial of rapid tranquilization with I.M. clonazepam and I.M. haloperidol in agitated psychotic patients with manic symptoms.Can J Psychiatry. 1993 Nov;38 Suppl 4:S114-21. Can J Psychiatry. 1993. PMID: 8306241 Clinical Trial.
-
Droperidol vs. haloperidol in the initial management of acutely agitated patients.J Clin Psychiatry. 1984 Jul;45(7):298-9. J Clin Psychiatry. 1984. PMID: 6376480 Clinical Trial.
-
Rapid parenteral treatment of acute psychosis.Compr Psychiatry. 1981 Jul-Aug;22(4):351-61. doi: 10.1016/0010-440x(81)90018-3. Compr Psychiatry. 1981. PMID: 6114808 Review. No abstract available.
-
Overview: efficacy and safety of the rapid neuroleptization method with injectable haloperidol.Am J Psychiatry. 1979 Mar;136(3):273-8. doi: 10.1176/ajp.136.3.273. Am J Psychiatry. 1979. PMID: 369395 Review.
Cited by
-
Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders.Cochrane Database Syst Rev. 2015 Jan 16;1(1):CD009831. doi: 10.1002/14651858.CD009831.pub2. Cochrane Database Syst Rev. 2015. PMID: 25592299 Free PMC article.
-
Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation).Cochrane Database Syst Rev. 2017 Jul 31;7(7):CD009377. doi: 10.1002/14651858.CD009377.pub3. Cochrane Database Syst Rev. 2017. PMID: 28758203 Free PMC article.
-
Antipsychotic medication for elderly people with schizophrenia.Cochrane Database Syst Rev. 2006 Jan 25;2006(1):CD005580. doi: 10.1002/14651858.CD005580. Cochrane Database Syst Rev. 2006. PMID: 16437531 Free PMC article.
-
'As required' medication regimens for seriously mentally ill people in hospital.Cochrane Database Syst Rev. 2015 Dec 21;2015(12):CD003441. doi: 10.1002/14651858.CD003441.pub3. Cochrane Database Syst Rev. 2015. PMID: 26689942 Free PMC article.
-
Emergency treatment of psychotic symptoms. Pharmacokinetic considerations for antipsychotic drugs.Clin Pharmacokinet. 1995 Jun;28(6):494-504. doi: 10.2165/00003088-199528060-00007. Clin Pharmacokinet. 1995. PMID: 7656507 Review.